Pain During Chest Tube Withdrawal: Evaluation Using Pan Monitor
Pain Drain
2 other identifiers
observational
100
1 country
1
Brief Summary
Pain evaluation remains a clinical problem. Pain Monitor allows pain evaluation using the measurement of skin conductance. Withdrawal of chest tube can be painful and the purpose of the study was to compare auto-evaluation of pain (visual analogic scale) and the index measured by the Pain Monitor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 10, 2013
CompletedFirst Posted
Study publicly available on registry
December 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedOctober 31, 2016
October 1, 2016
11 months
December 10, 2013
October 28, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Pain monitor evaluation of pain
Comparison between Pain monitor index and auto-evaluation of pain (numerical scale from 0 -no pain- to 10 - maximal pain)
1 hour
Secondary Outcomes (1)
Pain intensity
1 hour
Study Arms (2)
Epidural analgesia
Postoperative patients with epidural analgesia
Oral analgesics
Postoperative patients with oral analgesics
Interventions
Eligibility Criteria
Lung surgical patients
You may qualify if:
- patients undergoing removal of a chest tube after lung surgery,
- patients able to indicate the pain score.
You may not qualify if:
- pregnancy, lactation ,
- insulin-dependent diabetes with dysautonomia,
- central or peripheral neurological disease, agitation,
- inability to understand the protocol,
- inability to use the Pain Monitor: skin abnormalities at the site of measurement, pacemaker or implantable defibrillator, condition affecting the sympathetic nervous system, tremor of the extremities,
- contra-indication to oral morphine ,
- respiratory failure, severe hepatic insufficiency, intracranial hypertension, epilepsy associations
- recent administration of neostigmine or of atropine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital Fochlead
Study Sites (1)
Hopital Foch
Suresnes, 92150, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marc Fischler
Hôpital Foch
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2013
First Posted
December 19, 2013
Study Start
June 1, 2013
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
October 31, 2016
Record last verified: 2016-10